These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 33859746)

  • 1. Cannabidiol attenuates pulmonary arterial hypertension by improving vascular smooth muscle cells mitochondrial function.
    Lu X; Zhang J; Liu H; Ma W; Yu L; Tan X; Wang S; Ren F; Li X; Li X
    Theranostics; 2021; 11(11):5267-5278. PubMed ID: 33859746
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of Celastramycin as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension.
    Kurosawa R; Satoh K; Kikuchi N; Kikuchi H; Saigusa D; Al-Mamun ME; Siddique MAH; Omura J; Satoh T; Sunamura S; Nogi M; Numano K; Miyata S; Uruno A; Kano K; Matsumoto Y; Doi T; Aoki J; Oshima Y; Yamamoto M; Shimokawa H
    Circ Res; 2019 Jul; 125(3):309-327. PubMed ID: 31195886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of DP1 Aggravates Vascular Remodeling in Pulmonary Arterial Hypertension via mTORC1 Signaling.
    He Y; Zuo C; Jia D; Bai P; Kong D; Chen D; Liu G; Li J; Wang Y; Chen G; Yan S; Xiao B; Zhang J; Piao L; Li Y; Deng Y; Li B; Roux PP; Andreasson KI; Breyer RM; Su Y; Wang J; Lyu A; Shen Y; Yu Y
    Am J Respir Crit Care Med; 2020 May; 201(10):1263-1276. PubMed ID: 31917615
    [No Abstract]   [Full Text] [Related]  

  • 4. Dynamin-related protein 1-mediated mitochondrial mitotic fission permits hyperproliferation of vascular smooth muscle cells and offers a novel therapeutic target in pulmonary hypertension.
    Marsboom G; Toth PT; Ryan JJ; Hong Z; Wu X; Fang YH; Thenappan T; Piao L; Zhang HJ; Pogoriler J; Chen Y; Morrow E; Weir EK; Rehman J; Archer SL
    Circ Res; 2012 May; 110(11):1484-97. PubMed ID: 22511751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
    Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
    Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-Like Peptide-1 Receptor Agonist Attenuates Autophagy to Ameliorate Pulmonary Arterial Hypertension through Drp1/NOX- and Atg-5/Atg-7/Beclin-1/LC3β Pathways.
    Wu YC; Wang WT; Lee SS; Kuo YR; Wang YC; Yen SJ; Lee MY; Yeh JL
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial Hypertension.
    Vitry G; Paulin R; Grobs Y; Lampron MC; Shimauchi T; Lemay SE; Tremblay E; Habbout K; Awada C; Bourgeois A; Nadeau V; Paradis R; Breuils-Bonnet S; Roux-Dalvai F; Orcholski M; Potus F; Provencher S; Boucherat O; Bonnet S
    Am J Respir Crit Care Med; 2021 Mar; 203(5):614-627. PubMed ID: 33021405
    [No Abstract]   [Full Text] [Related]  

  • 8. PFKFB3 in Smooth Muscle Promotes Vascular Remodeling in Pulmonary Arterial Hypertension.
    Kovacs L; Cao Y; Han W; Meadows L; Kovacs-Kasa A; Kondrikov D; Verin AD; Barman SA; Dong Z; Huo Y; Su Y
    Am J Respir Crit Care Med; 2019 Sep; 200(5):617-627. PubMed ID: 30817168
    [No Abstract]   [Full Text] [Related]  

  • 9. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
    Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY
    Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia induces pulmonary artery smooth muscle dysfunction through mitochondrial fragmentation-mediated endoplasmic reticulum stress.
    Zhuan B; Wang X; Wang MD; Li ZC; Yuan Q; Xie J; Yang Z
    Aging (Albany NY); 2020 Nov; 12(23):23684-23697. PubMed ID: 33221740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial hyperpolarization in pulmonary vascular remodeling. Mitochondrial uncoupling protein deficiency as disease model.
    Pak O; Sommer N; Hoeres T; Bakr A; Waisbrod S; Sydykov A; Haag D; Esfandiary A; Kojonazarov B; Veit F; Fuchs B; Weisel FC; Hecker M; Schermuly RT; Grimminger F; Ghofrani HA; Seeger W; Weissmann N
    Am J Respir Cell Mol Biol; 2013 Sep; 49(3):358-67. PubMed ID: 23590303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactive Compounds From Coptidis Rhizoma Alleviate Pulmonary Arterial Hypertension by Inhibiting Pulmonary Artery Smooth Muscle Cells' Proliferation and Migration.
    Luo S; Kan J; Zhang J; Ye P; Wang D; Jiang X; Li M; Zhu L; Gu Y
    J Cardiovasc Pharmacol; 2021 Aug; 78(2):253-262. PubMed ID: 34554677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorinated perhexiline derivative attenuates vascular proliferation in pulmonary arterial hypertension smooth muscle cells.
    Griffiths K; Grand RJ; Horan I; Certo M; Keeler RC; Mauro C; Tseng CC; Greig I; Morrell NW; Zanda M; Frenneaux MP; Madhani M
    Vascul Pharmacol; 2024 Sep; 156():107399. PubMed ID: 38901807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maresin-1 protects against pulmonary arterial hypertension by improving mitochondrial homeostasis through ALXR/HSP90α axis.
    Liu M; He H; Fan F; Qiu L; Zheng F; Guan Y; Yang G; Chen L
    J Mol Cell Cardiol; 2023 Aug; 181():15-30. PubMed ID: 37244057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-Bromopyruvate ameliorates pulmonary arterial hypertension by improving mitochondrial metabolism.
    Guo Y; Liu X; Zhang Y; Qiu H; Ouyang F; He Y
    Life Sci; 2020 Sep; 256():118009. PubMed ID: 32603819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NDUFA4L2 in smooth muscle promotes vascular remodeling in hypoxic pulmonary arterial hypertension.
    Liu Y; Nie X; Zhu J; Wang T; Li Y; Wang Q; Sun Z
    J Cell Mol Med; 2021 Jan; 25(2):1221-1237. PubMed ID: 33340241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension.
    Van der Feen DE; Kurakula K; Tremblay E; Boucherat O; Bossers GPL; Szulcek R; Bourgeois A; Lampron MC; Habbout K; Martineau S; Paulin R; Kulikowski E; Jahagirdar R; Schalij I; Bogaard HJ; Bartelds B; Provencher S; Berger RMF; Bonnet S; Goumans MJ
    Am J Respir Crit Care Med; 2019 Oct; 200(7):910-920. PubMed ID: 31042405
    [No Abstract]   [Full Text] [Related]  

  • 18. miR-143 and miR-145 promote hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells through regulating ABCA1 expression.
    Yue Y; Zhang Z; Zhang L; Chen S; Guo Y; Hong Y
    Cardiovasc Pathol; 2018; 37():15-25. PubMed ID: 30195228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canagliflozin ameliorates hypobaric hypoxia-induced pulmonary arterial hypertension by inhibiting pulmonary arterial smooth muscle cell proliferation.
    Tang L; Cai Q; Wang X; Li X; Li X; Chen L; Yang Y
    Clin Exp Hypertens; 2023 Dec; 45(1):2278205. PubMed ID: 37970663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypusine Signaling Promotes Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
    Lemay SE; Grobs Y; Romanet C; Martineau S; Salem M; Shimauchi T; Breuils-Bonnet S; Bourgeois A; Théberge C; Pelletier A; Potus F; Provencher S; Bonnet S; Boucherat O
    Am J Respir Crit Care Med; 2024 Jun; 209(11):1376-1391. PubMed ID: 38261723
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.